Cargando…
Healthcare-Associated Stenotrophomonas maltophilia Bacteraemia: Retrospective Evaluation of Treatment and Outcome
Introduction Stenotrophomonas maltophilia (SM) is one of the common gram-negative pathogens that cause nosocomial infections. The aim of the present study is to evaluate the treatment and outcome of SM bacteraemia. Materials and Methods We retrospectively evaluated antimicrobial treatment in adult p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604085/ https://www.ncbi.nlm.nih.gov/pubmed/34812302 http://dx.doi.org/10.7759/cureus.18916 |
_version_ | 1784601880270209024 |
---|---|
author | Tuncel, Tekin Akalın, Halis Payaslıoğlu, Melda Yılmaz, Emel Kazak, Esra Heper, Yasemin Özakın, Cüneyt |
author_facet | Tuncel, Tekin Akalın, Halis Payaslıoğlu, Melda Yılmaz, Emel Kazak, Esra Heper, Yasemin Özakın, Cüneyt |
author_sort | Tuncel, Tekin |
collection | PubMed |
description | Introduction Stenotrophomonas maltophilia (SM) is one of the common gram-negative pathogens that cause nosocomial infections. The aim of the present study is to evaluate the treatment and outcome of SM bacteraemia. Materials and Methods We retrospectively evaluated antimicrobial treatment in adult patients with nosocomial SM bacteraemia, with the 14th and 30th-day mortality as the outcome. Results In total, 140 adult patients with SM bacteraemia who were diagnosed between January 1, 2002, and December 31, 2016 were enrolled in the present study. Seventy-one (50.7%) patients were in the intensive care unit (ICU). The 14th and the 30th-day mortality rates were 32.9% (n=46) and 45.7% (n=64), respectively. Female sex (OR, 7.47; 95% CI 1.61-34.47, p<0.01), steroid use within the last month (OR, 10.2; 95% CI 1.27-82.27, p=0.029), Pittsburgh bacteraemia score (PBS) ≥4 (OR, 39.9; 95% CI 4.96-321.32, p<0.001) and solid organ malignancy (OR, 9.6; 95% CI 1.73-53.72, p<0.01) were independent risk factors for 14th day mortality. Removal of the catheter was an independent protective factor for both 14th (OR, 0.05; 95% CI 0.22-0.010, p<0.001) and 30th day (OR, 0.039;95% CI 0.164-0.009, p<0.001) mortality. We did not detect any difference between treatment regimens including trimethoprim-sulfamethoxazole (TMP/SMX) or levofloxacin in terms of mortality. We found that TMP/SMX and levofloxacin combination did not significantly improve patient prognosis. Conclusion Due to the high mortality rates associated with nosocomial SM bacteraemia, adequate antibiotic therapy should be initiated immediately in the suspicion of infection, and prompt removal of any indwelling central venous catheter is important. |
format | Online Article Text |
id | pubmed-8604085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-86040852021-11-21 Healthcare-Associated Stenotrophomonas maltophilia Bacteraemia: Retrospective Evaluation of Treatment and Outcome Tuncel, Tekin Akalın, Halis Payaslıoğlu, Melda Yılmaz, Emel Kazak, Esra Heper, Yasemin Özakın, Cüneyt Cureus Internal Medicine Introduction Stenotrophomonas maltophilia (SM) is one of the common gram-negative pathogens that cause nosocomial infections. The aim of the present study is to evaluate the treatment and outcome of SM bacteraemia. Materials and Methods We retrospectively evaluated antimicrobial treatment in adult patients with nosocomial SM bacteraemia, with the 14th and 30th-day mortality as the outcome. Results In total, 140 adult patients with SM bacteraemia who were diagnosed between January 1, 2002, and December 31, 2016 were enrolled in the present study. Seventy-one (50.7%) patients were in the intensive care unit (ICU). The 14th and the 30th-day mortality rates were 32.9% (n=46) and 45.7% (n=64), respectively. Female sex (OR, 7.47; 95% CI 1.61-34.47, p<0.01), steroid use within the last month (OR, 10.2; 95% CI 1.27-82.27, p=0.029), Pittsburgh bacteraemia score (PBS) ≥4 (OR, 39.9; 95% CI 4.96-321.32, p<0.001) and solid organ malignancy (OR, 9.6; 95% CI 1.73-53.72, p<0.01) were independent risk factors for 14th day mortality. Removal of the catheter was an independent protective factor for both 14th (OR, 0.05; 95% CI 0.22-0.010, p<0.001) and 30th day (OR, 0.039;95% CI 0.164-0.009, p<0.001) mortality. We did not detect any difference between treatment regimens including trimethoprim-sulfamethoxazole (TMP/SMX) or levofloxacin in terms of mortality. We found that TMP/SMX and levofloxacin combination did not significantly improve patient prognosis. Conclusion Due to the high mortality rates associated with nosocomial SM bacteraemia, adequate antibiotic therapy should be initiated immediately in the suspicion of infection, and prompt removal of any indwelling central venous catheter is important. Cureus 2021-10-20 /pmc/articles/PMC8604085/ /pubmed/34812302 http://dx.doi.org/10.7759/cureus.18916 Text en Copyright © 2021, Tuncel et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Tuncel, Tekin Akalın, Halis Payaslıoğlu, Melda Yılmaz, Emel Kazak, Esra Heper, Yasemin Özakın, Cüneyt Healthcare-Associated Stenotrophomonas maltophilia Bacteraemia: Retrospective Evaluation of Treatment and Outcome |
title | Healthcare-Associated Stenotrophomonas maltophilia Bacteraemia: Retrospective Evaluation of Treatment and Outcome |
title_full | Healthcare-Associated Stenotrophomonas maltophilia Bacteraemia: Retrospective Evaluation of Treatment and Outcome |
title_fullStr | Healthcare-Associated Stenotrophomonas maltophilia Bacteraemia: Retrospective Evaluation of Treatment and Outcome |
title_full_unstemmed | Healthcare-Associated Stenotrophomonas maltophilia Bacteraemia: Retrospective Evaluation of Treatment and Outcome |
title_short | Healthcare-Associated Stenotrophomonas maltophilia Bacteraemia: Retrospective Evaluation of Treatment and Outcome |
title_sort | healthcare-associated stenotrophomonas maltophilia bacteraemia: retrospective evaluation of treatment and outcome |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604085/ https://www.ncbi.nlm.nih.gov/pubmed/34812302 http://dx.doi.org/10.7759/cureus.18916 |
work_keys_str_mv | AT tunceltekin healthcareassociatedstenotrophomonasmaltophiliabacteraemiaretrospectiveevaluationoftreatmentandoutcome AT akalınhalis healthcareassociatedstenotrophomonasmaltophiliabacteraemiaretrospectiveevaluationoftreatmentandoutcome AT payaslıoglumelda healthcareassociatedstenotrophomonasmaltophiliabacteraemiaretrospectiveevaluationoftreatmentandoutcome AT yılmazemel healthcareassociatedstenotrophomonasmaltophiliabacteraemiaretrospectiveevaluationoftreatmentandoutcome AT kazakesra healthcareassociatedstenotrophomonasmaltophiliabacteraemiaretrospectiveevaluationoftreatmentandoutcome AT heperyasemin healthcareassociatedstenotrophomonasmaltophiliabacteraemiaretrospectiveevaluationoftreatmentandoutcome AT ozakıncuneyt healthcareassociatedstenotrophomonasmaltophiliabacteraemiaretrospectiveevaluationoftreatmentandoutcome |